Published • loading... • Updated
Recent Analysts’ Ratings Updates for Syndax Pharmaceuticals (SNDX)
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Recent Analysts’ Ratings Updates for Syndax Pharmaceuticals (SNDX)
Several analysts have recently updated their ratings and price targets for Syndax Pharmaceuticals (NASDAQ: SNDX): 10/1/2026 – Syndax Pharmaceuticals had its “buy” rating reaffirmed by HC Wainwright. 10/1/2026 – Syndax Pharmaceuticals had its “buy” rating reaffirmed by UBS Group AG. 9/29/2026 – Syndax Pharmaceuticals had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. They […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
